SeQuent Scientific Ltd. plans to merge with Viyash Life Sciences Pvt. Ltd. and its group companies, along with its subsidiary Sequent Research Ltd., subject to regulatory approvals, based on valuations from KPMG and PWC. The merger is part of a strategic amalgamation without cash consideration or issuance of securities.